In 2018, a nitrosamine impurity (N-nitrosodimethylamine or “NDMA”) was detected in several pharmaceutical drugs containing the active ingredient valsartan, which resulted in a voluntary product recall ...
Several sartan, ranitidine, and metformin-based drug products have been recalled due to nitrosamine contamination, in unacceptable amounts, in these drugs. Since then, there has been increased ...
Ascend Laboratories, maker of generic dabigatran etexilate, is recalling 10 manufacturing lots of the oral anticoagulant because of an unacceptably high level of a possible carcinogen, according to a ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has ordered the recall of over 580,000 bottles of a commonly prescribed blood pressure drug ...
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from ...
The FDA has designated this a Class II recall. Over 7100 bottles of duloxetine have been recalled due to the presence of a nitrosamine impurity, N-nitroso-duloxetine, according to the Food and Drug ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK — A widespread recall of common ...
March 4 (Reuters) - Pfizer Canada was recalling blood pressure drug Accuretic due to the presence of a potential cancer-causing impurity called N-nitroso-quinapril, the Canadian health regulator said ...
In 2018, a nitrosamine impurity (N-nitrosodimethylamine or “NDMA”) was detected in several pharmaceutical drugs containing the active ingredient valsartan, which resulted in a voluntary product recall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results